For research and educational purposes only. Not medical advice.
Insulin degludec Reference
Educational, not medical advice reference for Insulin degludec: Hormonal, Metabolic; regulatory status, evidence posture, source review, and schedule notes.…
Reference summary
Insulin degludec is a label-verified ultra-long-acting basal insulin analog. pepSmart surfaces label-reference content only.
- Categories
- Hormonal, Metabolic
- Aliases
- Tresiba, Ultra-long-acting basal insulin analog
- Evidence posture
- human — Prescription basal insulin. Severe hypoglycemia risk — incorrect dosing can be fatal. Not a research compound. Clinician-directed individualized titration is the only safe use.
- Regulatory status
- FDA-approved prescription medication (Tresiba). Indicated as basal insulin therapy in type 1 and type 2 diabetes. Prescription-only.
- Content review status
- label verified